Thanks for that link Tony, but unfortunately much has changed...

Thanks for that link Tony, but unfortunately much has changed since late October for CGP.

We now have 3 products not 4 after Aspen's Nano technology cancer tumour patent project was discontinued. Nick didn't mention this project on the video, but it was cancelled during the AusBio conference period. See the asx announcement date 1/11/12.

Also our discussions on a global licencing deal for Breathe Assist has fallen through. A supposed $30m 5 yr deal has been terminated by the company.

Throw in dilution via Lind Partners, board changes, cost cutting programs and the CR & SPP announced recently and its been a terrible few months for cgp shareholders, which has been clearly reflected in the SP - now at an all time low.

As a non holder you're in an enviable position, so keep doing your DD.